Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Mesothelioma 58Mesothelioma, Malignant 51Advanced Solid Tumors 51Solid Tumors 43Solid Tumor 35Advanced Solid Tumor 22Carcinoma, Non-Small-Cell Lung 20Lung Neoplasms 12Ovarian Neoplasms 10Melanoma 10Esophageal Neoplasms 10Stomach Neoplasms 9Small Cell Lung Carcinoma 9Retinoblastoma 9Carcinoma, Renal Cell 9Unspecified Adult Solid Tumor, Protocol Specific 8Solitary Fibrous Tumor, Pleural 8Sarcoma 8Pancreatic Neoplasms 8Neoplasm Metastasis 8Breast Neoplasms 7Uterine Cervical Neoplasms 6Malignant Solid Tumor 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Solid Tumor, Adult 5Osteosarcoma 5Metastatic Solid Tumors 5Liver Neoplasms 5Colorectal Neoplasms 5

Interventions

molibresib 1enzalutamide 1abiraterone 1Prednisone 1Moxifloxacin 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Solid Tumours × Other solid neoplasm × Clear all
NCT03150056 2022-08-10

Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer

GlaxoSmithKline

Phase 1 Terminated
73 enrolled 34 charts
Other solid neoplasm

Solid Tumours

NCT02056392 2015-11-09

To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers

AstraZeneca

Phase 1 Completed
54 enrolled 31 charts
Other solid neoplasm

Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡